The3D-printed titanium mandibular (jaw) advancement device is engineered with a separate airway to direct air to the back of the mouth.

The device will bypass obstructions in the nose, back of the mouth and tongue.

Australian dentist Dr Chris Hart developed the device to reduce or eliminate snoring and obstructive sleep apnea (OSA).

Dr. Hart said: "The recent clinical trial data strongly showed that the O2Vent significantly reduced snoring and sleep apnea in most patients studied, even in those who historically did not benefit from other treatments due to chronic nasal obstruction.

"A greater number of patients who snore or who suffer from mild to moderate sleep apnea but who are CPAP intolerant, now have an alternative treatment option available."

According to the company, the O2Vent’s recent clinical study in Australia showed that snoring was eliminated in 82% of patients and significantly reduced in all 100% of patients in the trial.

In March this year, the company received 510(k) clearance from the US Food and Drug Administration (FDA) for O2Vent device.

The firm is planning the commercial sale of the device in the US later this year.

The company has showcased the device at the American Academy of Dental Sleep Medicine’s 25th annual meeting. It is also exhibiting O2Vent at Sleep 2016 in Denver, which is being held from 11 to 15 June.